Skip to main content
Equibles
WVE logo

WVE · Wave Life Sciences, Inc. · Earnings Call Transcripts & Audio

Track WVE — free

Use WVE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WVE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.70 +0.06 (+1.65%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$744.84M
Shares
197.05M
Volume · Sep 30 4.21M Avg daily vol (3M) 3.05M

Wave Life Sciences, Inc. Earnings Call Transcripts

Quarterly earnings calls for Wave Life Sciences, Inc. (WVE), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼99.2% $285,000 −$39.00M '22 Q3 22-11-10 · $1.24M −$43.71M '22 Q4 23-03-22 ▲638.8% $12.93M −$27.41M '23 Q1 23-05-03 ▲5794.9% $22.11M −$21.10M '23 Q2 23-08-03 ▲17168.1% $49.21M $7.25M '23 Q3 23-11-09 ▲2245.1% $29.06M −$16.26M '23 Q4 24-03-06 ▼3% $12.54M −$31.56M '24 Q1 24-05-09 ▼10.9% $19.69M −$32.92M '24 Q2 24-08-08 ▼26.8% $9.18M −$46.88M '25 Q1 25-05-08 ▼55.8% $8.70M −$50.47M '25 Q2 25-07-30 ▲316.9% $38.25M −$26.09M '26 Q1 26-04-28 LATEST ▼73.9% $2.27M −$69.36M '26 Q2 26-07-30
Conference
Investor event
2026-08-12
Wave Life Sciences, Inc. (WVE) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-30
Wave Life Sciences, Inc. (WVE) Q2 2026 Earnings Call Transcript
Confident tone WVE-007 obesity siRNA program Phase 2A INLIGHT trial enrollment and design WVE-006 RNA editing for AATD
Revenue
$2.27M
▼ 73.9% YoY
Diluted EPS
$-0.34
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Wave Life Sciences, Inc. (WVE) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Wave Life Sciences, Inc. (WVE) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-28
Wave Life Sciences, Inc. (WVE) Q1 2026 Earnings Call Transcript
Confident tone WVE-007 / INHBE obesity program WVE-006 / AATD RNA editing Liver / NASH opportunity via INHBE
Revenue
$38.25M
▲ 316.9% YoY
Diluted EPS
$-0.13
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Wave Life Sciences, Inc. (WVE) Q4 2025 Earnings Call Transcript
Confident tone WVE-007 (INHBE) for obesity WVE-006 for AATD / RNA editing leadership WVE-008 for PNPLA3 liver disease
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-12-08
Wave Life Sciences, Inc. (WVE) Q3 2025 Earnings Call Transcript
Confident tone WVE-007 (inhibiting) obesity program 2026 clinical data catalysts WVE-006 AATD RNA editing
Diluted EPS
$-0.32
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
Wave Life Sciences, Inc. (WVE) Q2 2025 Earnings Call Transcript
Confident tone WVE-007 / INLIGHT obesity program (INHBE siRNA) Clinical readouts and data cadence FORWARD-53 DMD program (WVE-N531)
Revenue
$8.70M
▼ 55.8% YoY
Diluted EPS
$-0.31
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Wave Life Sciences, Inc. (WVE) Q1 2025 Earnings Call Transcript
Confident tone Obesity (WVE-007 / INHBE) AATD / RNA Editing (WVE-006) DMD / WVE-N531
Revenue
$9.18M
▼ 26.8% YoY
Diluted EPS
$-0.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Wave Life Sciences, Inc. (WVE) Q4 2024 Earnings Call Transcript
Confident tone WVE-007 obesity program and GLP-1 positioning WVE-006 AATD RNA editing program WVE-003 Huntington's disease allele-selective program
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Wave Life Sciences, Inc. (WVE) Q3 2024 Earnings Call Transcript
Confident tone Regulatory path and FDA interactions DMD program WVE-N531 (FORWARD-53) Platform differentiation and competition
Diluted EPS
$-0.47
▼ 771.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Wave Life Sciences, Inc. (WVE) Q2 2024 Earnings Call Transcript
Confident tone WVE-003 / Huntington's disease (SELECT-HD) WVE-007 / Obesity siRNA WVE-006 / RNA editing for AATD
Revenue
$19.69M
▼ 10.9% YoY
Diluted EPS
$-0.25
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Wave Life Sciences, Inc. (WVE) Q1 2024 Earnings Call Transcript
Confident tone RNA editing pipeline / WVE-006 (AATD) GSK collaboration Clinical milestones / upcoming catalysts
Revenue
$12.54M
▼ 3% YoY
Diluted EPS
$-0.24
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-06
Wave Life Sciences, Inc. (WVE) Q4 2023 Earnings Call Transcript
Confident tone INHBE obesity program WVE-006 / AATD RNA editing program DMD / WVE-N531 exon skipping
Revenue
$29.06M*
▲ 2245.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Wave Life Sciences, Inc. (WVE) Q3 2023 Earnings Call Transcript
Revenue
$49.21M
▲ 17168.1% YoY
Diluted EPS
$0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Wave Life Sciences, Inc. (WVE) Q2 2023 Earnings Call Transcript
Revenue
$22.11M
▲ 5794.9% YoY
Diluted EPS
$-0.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Wave Life Sciences, Inc. (WVE) Q1 2023 Earnings Call Transcript
Revenue
$12.93M
▲ 638.8% YoY
Diluted EPS
$-0.27
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-22
Wave Life Sciences, Inc. (WVE) Q4 2022 Earnings Call Transcript
Revenue
$1.24M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Wave Life Sciences, Inc. (WVE) Q3 2022 Earnings Call Transcript
Revenue
$285,000
▼ 99.2% YoY
Diluted EPS
$-0.42
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Wave Life Sciences, Inc. (WVE) Q2 2022 Earnings Call Transcript
Revenue
$375,000
▼ 86.5% YoY
Diluted EPS
$-0.62
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Wave Life Sciences, Inc. (WVE) Q1 2022 Earnings Call Transcript
Revenue
$1.75M
Diluted EPS
$-0.62
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Wave Life Sciences, Inc. (WVE) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Wave Life Sciences, Inc. (WVE) Q3 2021 Earnings Call Transcript
Revenue
$36.42M
▲ 955.7% YoY
Diluted EPS
$-0.12
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Wave Life Sciences, Inc. (WVE) Q2 2021 Earnings Call Transcript
Revenue
$2.78M
▼ 8.3% YoY
Diluted EPS
$-0.78
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Wave Life Sciences, Inc. (WVE) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
Wave Life Sciences, Inc. (WVE) Q4 2020 Earnings Call Transcript
Revenue
$9.44M*
▲ 293.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Wave Life Sciences, Inc. (WVE) Q3 2020 Earnings Call Transcript
Revenue
$3.45M
▲ 17.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Wave Life Sciences, Inc. (WVE) Q2 2020 Earnings Call Transcript
Revenue
$3.03M
▼ 60.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Wave Life Sciences, Inc. (WVE) Q1 2020 Earnings Call Transcript
Revenue
$4.16M
▲ 37.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-02
Wave Life Sciences, Inc. (WVE) Q4 2019 Earnings Call
Revenue
$2.40M
▼ 33.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–30 of 30 earnings calls
Key facts CIK 1631574 CUSIP 94352A104 13F (30d) 4 filings 4 filers Visit website Investor relations